Concern over the use of recombinant bone morphogenetic protein in spinal fusion surgery: are stem cells an alternative?

被引：0

作者：

Oehme, David ^{[1
]}

Goldschlager, Tony ^{[1
,2
]}

Ghosh, Peter ^{[1
,3
]}

Jenkin, Graham ^{[1
]}

Rosenfeld, Jeffrey V. ^{[4
,5
]}

机构：

[1] Monash Univ, MIMR, Ritchie Ctr, Melbourne, Vic 3004, Australia

[2] Monash Med Ctr, Melbourne, Vic, Australia

[3] Proteobioactives, Proteobioact Res Labs Brookvale, Sydney, NSW, Australia

[4] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia

[5] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia

来源：

关键词：

SAFETY;

D O I：

10.1111/ans.12538

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：302 / 303

页数：2